The first major project of the Pediatric Cancer Moonshot 2020 Consortium with a $20MM Award from the Chan Soon-Shiong Institute of Molecular Medicine to enable the most comprehensive molecular analysis of brain tumors of all types in children
The goal is to release genomic, transcriptomic and proteomic data from 1,600 patients in next six months, representing the nation’s largest brain tumor atlas to date.
NantHealth, Inc.(Nasdaq: NH), a leading next-generation, evidence-based, personalized healthcare company, the Chan Soon-Shiong Institute of Molecular Medicine and the collaborators of the Pediatric Cancer Moonshot 2020 today announced that they are embarking on one of the world’s most ambitious pediatric sequencing discovery projects to date. This initiative will focus on the largest killer of pediatric cancer patients today: childhood brain tumors.
Read Full Article Here >>